Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B

被引：0
|
作者：
Tao Chen
Lin Zhu
Aichao Shi
Lin Ding
Xiaoping Zhang
Zhenmin Tan
Wei Guo
Weiming Yan
Meifang Han
Jidong Jia
Xiaoping Luo
Detlef Schuppan
Qin Ning
机构：
[1] Huazhong University of Science and Technology,Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College
[2] Capital Medical University,Liver Research Center, Beijing Friendship Hospital
[3] Huazhong University of Science and Technology,Department of Pediatrics, Tongji Hospital, Tongji Medical College
[4] Johannes-Gutenberg-University,Institute of Translational Immunology, University Medical Center and Research Center for Immune Therapy
[5] Harvard Medical School,Division of Gastroenterology, Beth Israel Deaconess Medical Center
来源：
Hepatology International | 2017年 / 11卷
关键词：
Natural killer cells; Chronic hepatitis B; Telbivudine; NKG2D; IL-15;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：419 / 428
页数：9
相关论文
共 17 条
  • [1] Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B
    Chen, Tao
    Zhu, Lin
    Shi, Aichao
    Ding, Lin
    Zhang, Xiaoping
    Tan, Zhenmin
    Guo, Wei
    Yan, Weiming
    Han, Meifang
    Jia, Jidong
    Luo, Xiaoping
    Schuppan, Detlef
    Ning, Qin
    HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 419 - 428
  • [2] Functional restoration of CD56bright NK cells via IL-15 and NKG2D correlates with antiviral treatment efficacy in chronic hepatitis B patients
    Chen, Tao
    Shi, Aichao
    Zhang, Xiaoping
    Zhu, Lin
    Wu, Zeguang
    Yan, Weiming
    Wang, Xiaojing
    Ma, Hong
    Jia, Jidong
    Guo, Wei
    Ning, Qin
    HEPATOLOGY, 2015, 62 : 1018A - 1018A
  • [3] NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype:: regulation by histamine and reactive oxygen species
    Romero, A
    Thorén, F
    Movitz, C
    Betten, Å
    Hellstrand, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, : 69 - 69
  • [4] NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype:: regulation by histamine and reactive oxygen species
    Romero, AI
    Thorén, FB
    Brune, M
    Hellstrand, K
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (01) : 91 - 98
  • [5] Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsets
    Desimio, Maria Giovanna
    Covino, Daniela Angela
    Cancrini, Caterina
    Doria, Margherita
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
    Nielsen, Natasja
    Odum, Niels
    Urso, Birgitte
    Lanier, Lewis L.
    Spee, Pieter
    PLOS ONE, 2012, 7 (02):
  • [7] IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis
    Fan, Jing
    Xu, Min
    Liu, Ke
    Yan, Wanping
    Wu, Huanyu
    Dong, Hongliang
    Yang, Yongfeng
    Ye, Wei
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (10)
  • [8] HIGH NUMBERS OF CD56BRIGHT, CD56DIM/NKG2D+ AND LOW NUMBERS OF CD3-CD56-CD16+ NK-CELLS ARE ASSOCIATED WITH LOW HCV-SPECIFIC IL-10 PRODUCTION AND PREDICT TREATMENT-RESPONSE IN CHRONIC HEPATITIS C
    Carey, I.
    Mendes, A.
    Scalori, A.
    Joshi, D.
    Agarwal, K.
    Mieli-Vergani, G.
    Vergani, D.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S452 - S453
  • [9] IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway
    Li, Yanping
    Li, Yonglin
    Xiang, Bin
    Tian, Xiaomao
    Shi, Qinlin
    Liu, Feng
    Lin, Tao
    Wei, Guanghui
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [10] NK cells are primed by ANRS MVAHIV-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to control HIV-1 infection in CD4+ T cells
    Moreno-Nieves, Uriel Y.
    Didier, Celine
    Levy, Yves
    Barre-Sinoussi, Francoise
    Scott-Algara, Daniel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (08) : 2370 - 2379
12